Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901 2006, as amended Seretide Evohaler Viani Evohaler, Seretide Diskus Viani - Fluticasone propionate salmeterol - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2011-01-05 07:16:25 GlaxoSmithKline Asthma Phenethylamines Organofluorides Fluticasone/salmeterol Salmeterol Fluticasone propionate Inhaler Salbutamol Pulmonology Medicine Respiratory therapy		Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani Add to Reading List Source URL: www.hma.eu Download Document from Source Website File Size: 226,97 KB Share Document on Facebook

	Microsoft Word - Prosonix full abstract for DDL22_2_.doc DocID: 1rcKt - View Document
	COPD Care Map for Primary Care Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________ DocID: 1qO6l - View Document
	Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth DocID: 1oNoo - View Document
	European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using DocID: 1ooQZ - View Document
	PIPELINE WATCH Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European DocID: 1mZXk - View Document